Stonebridge Capital Advisors LLC Charles River Laboratories International, Inc. Transaction History

Stonebridge Capital Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$194.44 - $217.61 $4,472 - $5,005	-23 Reduced 88.46%	3 $0
Q2 2023 Aug 23, 2023	BUY	$183.71 - $210.25 $4,225 - $4,835	23 Added 766.67%	26 $5,000
Q4 2022 Feb 14, 2023	SELL	$197.11 - $250.07 $6,110 - $7,752	-31 Reduced 91.18%	3 $0
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $1,641 - $2,254	9 Added 36.0%	34 $7,000
Q3 2021 Nov 15, 2021	BUY	$372.64 - $458.3 $9,316 - $11,457	25 New	25 $10,000

691

51.6M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.38B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Stonebridge Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Stonebridge Capital Advisors LLC with notifications on news.